351 related articles for article (PubMed ID: 29331171)
1. The genotypic and phenotypic spectrum of MTO1 deficiency.
O'Byrne JJ; Tarailo-Graovac M; Ghani A; Champion M; Deshpande C; Dursun A; Ozgul RK; Freisinger P; Garber I; Haack TB; Horvath R; Barić I; Husain RA; Kluijtmans LAJ; Kotzaeridou U; Morris AA; Ross CJ; Santra S; Smeitink J; Tarnopolsky M; Wortmann SB; Mayr JA; Brunner-Krainz M; Prokisch H; Wasserman WW; Wevers RA; Engelke UF; Rodenburg RJ; Ting TW; McFarland R; Taylor RW; Salvarinova R; van Karnebeek CDM
Mol Genet Metab; 2018 Jan; 123(1):28-42. PubMed ID: 29331171
[TBL] [Abstract][Full Text] [Related]
2. MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast.
Baruffini E; Dallabona C; Invernizzi F; Yarham JW; Melchionda L; Blakely EL; Lamantea E; Donnini C; Santra S; Vijayaraghavan S; Roper HP; Burlina A; Kopajtich R; Walther A; Strom TM; Haack TB; Prokisch H; Taylor RW; Ferrero I; Zeviani M; Ghezzi D
Hum Mutat; 2013 Nov; 34(11):1501-9. PubMed ID: 23929671
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis.
Ghezzi D; Baruffini E; Haack TB; Invernizzi F; Melchionda L; Dallabona C; Strom TM; Parini R; Burlina AB; Meitinger T; Prokisch H; Ferrero I; Zeviani M
Am J Hum Genet; 2012 Jun; 90(6):1079-87. PubMed ID: 22608499
[TBL] [Abstract][Full Text] [Related]
4. A novel TUFM homozygous variant in a child with mitochondrial cardiomyopathy expands the phenotype of combined oxidative phosphorylation deficiency 4.
Hershkovitz T; Kurolap A; Gonzaga-Jauregui C; Paperna T; Mory A; Wolf SE; ; Overton JD; Shuldiner AR; Saada A; Mandel H; Baris Feldman H
J Hum Genet; 2019 Jun; 64(6):589-595. PubMed ID: 30903008
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic analysis of combined oxidative phosphorylation defificiency-10 caused by MTO1 mutation.
Zhou C; Wang J; Zhang Q; Yang Q; Yi S; Shen Y; Luo J; Qin Z
Clin Chim Acta; 2022 Feb; 526():74-80. PubMed ID: 34990597
[TBL] [Abstract][Full Text] [Related]
6. MTO1 mediates tissue specificity of OXPHOS defects via tRNA modification and translation optimization, which can be bypassed by dietary intervention.
Tischner C; Hofer A; Wulff V; Stepek J; Dumitru I; Becker L; Haack T; Kremer L; Datta AN; Sperl W; Floss T; Wurst W; Chrzanowska-Lightowlers Z; De Angelis MH; Klopstock T; Prokisch H; Wenz T
Hum Mol Genet; 2015 Apr; 24(8):2247-66. PubMed ID: 25552653
[TBL] [Abstract][Full Text] [Related]
7. COXPD9 in an individual from Puerto Rico and literature review.
Alsharhan H; Muraresku C; Ganetzky RD
Am J Med Genet A; 2021 Aug; 185(8):2519-2525. PubMed ID: 34008913
[TBL] [Abstract][Full Text] [Related]
8. Ablation of Mto1 in zebrafish exhibited hypertrophic cardiomyopathy manifested by mitochondrion RNA maturation deficiency.
Zhang Q; He X; Yao S; Lin T; Zhang L; Chen D; Chen C; Yang Q; Li F; Zhu YM; Guan MX
Nucleic Acids Res; 2021 May; 49(8):4689-4704. PubMed ID: 33836087
[TBL] [Abstract][Full Text] [Related]
9. Defects in the mitochondrial-tRNA modification enzymes MTO1 and GTPBP3 promote different metabolic reprogramming through a HIF-PPARγ-UCP2-AMPK axis.
Boutoual R; Meseguer S; Villarroya M; Martín-Hernández E; Errami M; Martín MA; Casado M; Armengod ME
Sci Rep; 2018 Jan; 8(1):1163. PubMed ID: 29348686
[TBL] [Abstract][Full Text] [Related]
10. A novel compound heterozygous mutation of the MTO1 gene associated with complex oxidative phosphorylation deficiency type 10.
Luo Q; Wen X; Zhou J; Chen Y; Lv Z; Shen X; Liu J
Clin Chim Acta; 2021 Dec; 523():172-177. PubMed ID: 34547275
[TBL] [Abstract][Full Text] [Related]
11. Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy.
Kopajtich R; Nicholls TJ; Rorbach J; Metodiev MD; Freisinger P; Mandel H; Vanlander A; Ghezzi D; Carrozzo R; Taylor RW; Marquard K; Murayama K; Wieland T; Schwarzmayr T; Mayr JA; Pearce SF; Powell CA; Saada A; Ohtake A; Invernizzi F; Lamantea E; Sommerville EW; Pyle A; Chinnery PF; Crushell E; Okazaki Y; Kohda M; Kishita Y; Tokuzawa Y; Assouline Z; Rio M; Feillet F; Mousson de Camaret B; Chretien D; Munnich A; Menten B; Sante T; Smet J; Régal L; Lorber A; Khoury A; Zeviani M; Strom TM; Meitinger T; Bertini ES; Van Coster R; Klopstock T; Rötig A; Haack TB; Minczuk M; Prokisch H
Am J Hum Genet; 2014 Dec; 95(6):708-20. PubMed ID: 25434004
[TBL] [Abstract][Full Text] [Related]
12. A novel compound heterozygous mutation in VARS2 in a newborn with mitochondrial cardiomyopathy: a case report of a Chinese family.
Ma K; Xie M; He X; Liu G; Lu X; Peng Q; Zhong B; Li N
BMC Med Genet; 2018 Nov; 19(1):202. PubMed ID: 30458719
[TBL] [Abstract][Full Text] [Related]
13. Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules.
Leslie N; Wang X; Peng Y; Valencia CA; Khuchua Z; Hata J; Witte D; Huang T; Bove KE
Hum Pathol; 2016 Mar; 49():27-32. PubMed ID: 26826406
[TBL] [Abstract][Full Text] [Related]
14. Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies.
Feichtinger RG; Oláhová M; Kishita Y; Garone C; Kremer LS; Yagi M; Uchiumi T; Jourdain AA; Thompson K; D'Souza AR; Kopajtich R; Alston CL; Koch J; Sperl W; Mastantuono E; Strom TM; Wortmann SB; Meitinger T; Pierre G; Chinnery PF; Chrzanowska-Lightowlers ZM; Lightowlers RN; DiMauro S; Calvo SE; Mootha VK; Moggio M; Sciacco M; Comi GP; Ronchi D; Murayama K; Ohtake A; Rebelo-Guiomar P; Kohda M; Kang D; Mayr JA; Taylor RW; Okazaki Y; Minczuk M; Prokisch H
Am J Hum Genet; 2017 Oct; 101(4):525-538. PubMed ID: 28942965
[TBL] [Abstract][Full Text] [Related]
15. FBXL4 defects are common in patients with congenital lactic acidemia and encephalomyopathic mitochondrial DNA depletion syndrome.
Dai H; Zhang VW; El-Hattab AW; Ficicioglu C; Shinawi M; Lines M; Schulze A; McNutt M; Gotway G; Tian X; Chen S; Wang J; Craigen WJ; Wong LJ
Clin Genet; 2017 Apr; 91(4):634-639. PubMed ID: 27743463
[TBL] [Abstract][Full Text] [Related]
16. A very rare presentation of mitochondrial elongation factor Tu deficiency-
Gokalp S; Inci A; Kilic A; Ozsaydi E; Altun AN; Demir F; Ergin FB; Ozbek MN; Okur I; Ezgu F; Tumer L
J Pediatr Endocrinol Metab; 2024 Jun; 37(6):571-574. PubMed ID: 38630895
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial translation defect.
Friederich MW; Geddes GC; Wortmann SB; Punnoose A; Wartchow E; Knight KM; Prokisch H; Creadon-Swindell G; Mayr JA; Van Hove JLK
Mol Genet Metab; 2021 Aug; 133(4):362-371. PubMed ID: 34140213
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase 2 and alanyl-tRNA synthetase 2 deficiencies cause lethal mitochondrial cardiomyopathy: case reports and review of the literature.
Mazurova S; Magner M; Kucerova-Vidrova V; Vondrackova A; Stranecky V; Pristoupilova A; Zamecnik J; Hansikova H; Zeman J; Tesarova M; Honzik T
Cardiol Young; 2017 Jul; 27(5):936-944. PubMed ID: 27839525
[TBL] [Abstract][Full Text] [Related]
19. The genetic basis of isolated mitochondrial complex II deficiency.
Fullerton M; McFarland R; Taylor RW; Alston CL
Mol Genet Metab; 2020; 131(1-2):53-65. PubMed ID: 33162331
[TBL] [Abstract][Full Text] [Related]
20. Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion.
Huang X; Bedoyan JK; Demirbas D; Harris DJ; Miron A; Edelheit S; Grahame G; DeBrosse SD; Wong LJ; Hoppel CL; Kerr DS; Anselm I; Berry GT
Mol Genet Metab; 2017 Mar; 120(3):213-222. PubMed ID: 27913098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
